Wyeth
Wyeth is named on 13 US grants and 108 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 13
- Published applications
- 108
- Inventors
- 322
- Granted in 2026 so far
- 0
- Most recent grant
- 23 Feb 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 10 |
| 2004 | 0 | 9 |
| 2005 | 0 | 15 |
| 2006 | 0 | 10 |
| 2007 | 0 | 24 |
| 2008 | 4 | 15 |
| 2009 | 0 | 8 |
| 2010 | 0 | 5 |
| 2011 | 0 | 6 |
| 2012 | 4 | 3 |
| 2013 | 0 | 1 |
| 2014 | 4 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
By publication year.
Technology areas
Share of 121 documents
- A61PTherapeutic uses of medicines90
- A61KMedicines and medical preparations72
- C07KPeptides54
- C12NMicroorganisms or enzymes27
- G01NInvestigating or analysing materials by determining their chemical or physical properties24
- C07DHeterocyclic compounds23
- A61LMethods or apparatus for sterilising materials or objects in general22
- A01KAnimal husbandry17
- Y10TTechnical subjects covered by former us classification13
- A61FFilters implantable into blood vessels10
Recent patents
- Local vascular delivery of sirolimus to prevent restenosis following vascular injury23 Feb 2016US 9,265,598 B2
- Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury9 Sep 2014US 8,828,416 B2
- Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease22 Jul 2014US 8,784,860 B2
- Intraluminal medical devices in combination with therapeutic agents10 Jun 2014US 8,747,881 B2
- Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury18 Feb 2014US 8,652,502 B2
- Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders27 Mar 2014US 2014/0086920 A1
- Triazine compounds as pi3 kinase and mtor inhibitors3 Jan 2013US 2013/0005723 A1
- Mycoplasma hyopneumoniae bacterin vaccine23 Aug 2012US 2012/0213816 A1
- Treatment regimen utilizing neratinib for breast cancer22 Mar 2012US 2012/0071507 A1
- Formulation Comprising Bioactive Agents And Method Of Using Same5 Jan 2012US 2012/0004170 A1
Most cited
By later US patents
- Circovirus sequences associated with piglet weight loss disease (PWD)59US 7,407,803 B22008
- Circovirus sequences associated with piglet weight loss disease (PWD)59US 7,425,444 B22008
- Circovirus sequences associated with piglet weight loss disease (PWD)58US 7,390,494 B22008
- Circovirus sequences associated with piglet weight loss disease (PWD)57US 7,405,075 B22008
- Heparin barrier coating for controlled drug release31US 8,182,527 B22012